Monday, March 19, 2012

Natelle One





Dosage Form: capsule, gelatin coated
Natelle® One

Rx Prenatal Vitamin & Plant-Based DHA

Now with 28 mg Iron

Natelle One Description


Natelle® One capsules for oral administration are supplied as oblong red soft gelatin capsules, imprinted with "Natelle1" in white ink.


Each capsule contains:


Docosahexaenoic Acid (DHA) .........................................................250 mg


Eicosapentaenoic Acid (EPA)...............................Not more than 0.625mg


Calcium (Tricalcium Phosphate).......................................................102 mg


Iron (Ferrous Fumarate) ......................................................................28 mg


Vitamin C (Ascorbic Acid) ...................................................................30 mg


Vitamin B-6 (Pyridoxine HCl) ..............................................................25 mg


Vitamin E (D-Alpha Tocopherol) ..........................................................30 IU


Folic Acid .................................................................................................1 mg


DHA is an omega-3 fatty acid. The DHA in Natelle® One is derived from Algal Oil (C.cohnii). 625 mg of Algal Oil is equivalent to 250 mg of DHA.


Inactive Ingredients: Gelatin (Bovine), Beeswax, Glycerine, Soybean Oil, Lecithin, Titanium Dioxide, Ethyl Vanillin.



Indications and Usage for Natelle One


Natelle® One is indicated to provide vitamin/mineral and DHA omega–3 fatty acid supplementation to women throughout pregnancy, during the postnatal period for both lactating and non–lactating mothers, and throughout the childbearing years. Natelle® One may be beneficial in improving the nutritional status of women prior to conception.



Contraindications


This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.




WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. Keep this product out of the reach of children. In case of accidental overdose, call a doctor or poison control center immediately.




Warnings


Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.



Precautions


Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.



Pediatric Use


Safety and effectiveness in pediatric patients have not been established.



Geriatric Use


Clinical studies on this product have not been performed to determine whether elderly subjects respond differently from younger subjects.



Adverse Reactions


Allergic sensitization has been reported following both oral and parenteral administration of folic acid.



Natelle One Dosage and Administration


One capsule daily, or as directed by a physician.



How is Natelle One Supplied


Supplied in child resistant bottles of 30 capsules (NDC 18860-752-01).


Store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F).



KEEP THIS AND ALL DRUGS/MEDICATIONS OUT OF THE REACH OF CHILDREN.


Distributed by: Azur Pharma Inc. • 1818 Market Street, Suite 2350 • Philadelphia, PA 19103 • www.azurpharma.com


To report a serious adverse event or obtain product information, contact (800) 890 3098.



life’sDHA™ is a trademark of Martek Biosciences Corporation.


Natelle® is a registered trademark of Azur Pharma International II Limited.


Rx Only


NAT1w-11-01



Principal Display Panel - Bottle


30 Capsules


NDC 18860-752-01


Natelle® ONE


Rx Prenatal Vitamin & Plant-Based DHA.


Now with 28 mg Iron


Rx Only


Dist by: AZUR PHARMA INC.


1818 Market Street, Suite 2350


Philadelphia, PA 19103


www.azurpharma.com


Mfg by: Accucaps Industries Ltd


Windsor, Ontario, Canada


Natelle® is a registered trademark of Azur Pharma International II Limited.


Bottle Label




Principal Display Panel - Physician Sample Kit


Natelle® ONE


Rx Prenatal Vitamin & Plant-Based DHA


NDC 18860-752-00


ONE PHYSICIAN SAMPLING KIT


Contains 10 Patient Starter Kits, each containing 3 capsules


NOT FOR SALE


RX ONLY


Distributed by: AZUR PHARMA, INC.

1818 Market Street, Suite 2350 · Philadelphia, PA 19103 · www.azurpharma.com


Manufactured by: Accucaps Industries Ltd. Windsor, Ontario, Canada


Natelle® is a registered trademark of Azur Pharma International II Limited.


life'sDHA™ is a trademark of Market Biosciences Corporation.


Physicians Sample Kit










Natelle One 
doconexent,icosapent, tricalcium phosphate, ferrous fumarate, ascorbic acid, pyridoxine hydrochloride, alpha-tocopherol, and folic acid  capsule, gelatin coated










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)18860-752
Route of AdministrationORALDEA Schedule    





























Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCONEXENT (DOCONEXENT)DOCONEXENT250 mg
ICOSAPENT (ICOSAPENT)ICOSAPENT0.625 mg
TRICALCIUM PHOSPHATE (CALCIUM)TRICALCIUM PHOSPHATE102 mg
FERROUS FUMARATE (IRON)FERROUS FUMARATE28 mg
ASCORBIC ACID (ASCORBIC ACID)ASCORBIC ACID30 mg
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE)PYRIDOXINE HYDROCHLORIDE25 mg
ALPHA-TOCOPHEROL (ALPHA-TOCOPHEROL)ALPHA-TOCOPHEROL30 [iU]
FOLIC ACID (FOLIC ACID)FOLIC ACID1 mg


















Inactive Ingredients
Ingredient NameStrength
GELATIN 
GLYCERIN 
SOYBEAN OIL 
LECITHIN, SOYBEAN 
TITANIUM DIOXIDE 
ETHYL VANILLIN 
YELLOW WAX 


















Product Characteristics
ColorREDScoreno score
ShapeCAPSULE (oblong)Size25mm
FlavorImprint CodeNatelle1
Contains      














Packaging
#NDCPackage DescriptionMultilevel Packaging
118860-752-0130  In 1 BOTTLENone
218860-752-003  In 1 BLISTER PACKNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
Unapproved drug other06/11/2010


Labeler - Azur Pharma, Inc. (805611071)









Establishment
NameAddressID/FEIOperations
Accucaps Industries Limited248441727MANUFACTURE
Revised: 01/2012Azur Pharma, Inc.

No comments:

Post a Comment